BIIB News | BIIB Stock | Biogen News (#BIIB) Shareholders Class Action Lawsuit Biogen Inc $BIIB
Posted by FraudNewsWire
March 10, 2022

Deadline πŸ‘‰ April 8, 2022 BIIB News |BIIB Stock|Biogen News (#BIIB) Shareholders Class Action Lawsuit Biogen Inc $BIIB

BIIB News and BIIB Stock

The lawsuit, filed in the Eastern District of Massachusetts, seeks to recover shareholders’ losses with NO out-of-pocket cost.

The class action alleges that:

1. There was a significant, undisclosed lobbying campaign between Biogen and the Food and Drug Administration (β€œFDA”) that was instrumental in the decision to file and approve Aduhelm, a drug being developed to treat Alzheimer’s disease.

2. The Phase III ENGAGE study demonstrated that Aduhelm failed to achieve a clinical benefit to Alzheimer’s patients.

3. ENGAGE was a failed study from which Biogen concluded not to seek FDA approval for Aduhelm in 2019.

4. Defendants misled investors as to the way in which approval was achieved, that the clinical data did not support a clinical benefit by taking Aduhelm and that side-effects were dangerous and serious.

Investors who suffered losses on Biogen shares, only have until April 8, 2022 to request that the court appoint you as a lead plaintiff. Acting as a lead plaintiff is not a requirement to participate in monetary recovery, but you must meet the deadline to be considered as a lead plaintiff.

Vincent Wong Esq Law Offices is here to assist you to register click here πŸ‘‰

The Law Offices of Vincent Wong is a highly experienced corporate and securities firm concentrating in mergers and acquisitions, corporate finance, and securities law. We represent individual shareholders, private equity funds and investment banks in a variety of corporate transactional and litigation matters. Prior results do not guarantee similar outcomes, and this video may be considered attorney advertising under the laws of your state.

BIIB News and BIIB Stock

Keep track of your shares through our program partner, at no cost to you. Register on CORE. Join more than 150K users and protect your portfolio πŸ‘‰
___________________________ Visit Vincent Wong Law Firm _____________________
Website πŸ‘‰πŸ»

πŸ‰ Visit us on social media πŸ‰
Twitter πŸ‘‰πŸ»
Facebook πŸ‘‰πŸ»
Youtube πŸ‘‰πŸ»
Google πŸ‘‰πŸ»

______________________Time Stamp ⌚ ________________________
00:00 BIIB News
00:00 The class action alleges that
01:27 To Register
01:40 The Law Offices of Vincent Wong


Videos that discuss BIIB News and BIIB Stock

The RISE and FALL of Biogen Stock | BIIB Stock Analysis Everything Money
Biogen Stock Tumbles! Should You Buy The Dip? Global Money Academy
Biogen (BIIB) Stock | Long-Term Analysis | Overvalued or Undervalued | Money Regard
Biogen Stock Is UNDERVALUED! | $BIIB Stock Analysis Everything Money
Stock Analysis | Biogen Inc. (BIIB) Fatal Money
Biogen shares jump higher on report of potential Samsung acquisition CNBC Television
Indices Up & BIIB, MU, JBLU Stocks | #shorts TD Ameritrade Network

biogen or BIIB overvalued or undervalued or known as biogen stock news stock information shareholders, the rise and fall of biogen and biogen stock watch the biogen stock analysis for biogen stock price. biib is now looking for investors to investigate biib stock and biib stock analysis or biogen pharma stock deep dive into biogen stock latest news issues. biogen stock price drop risk or BIIB Long Term this video discusses investigation class action litigation.